Unlike other cancer predisposing syndromes, all variants reported in NTHL1 biallelic carriers are stop-gain, frameshift or canonical splice-site variants; no missense variants have been yet identified as cause of the disease (data obtained October 2020). The gene discussed is NTHL1; the disease is cancer.